In this paper, a highly selective molecularly imprinted polymer (MIP) for tramadol hydrochloride, a drug used to treat moderate to severe pain, was prepared and its use as solid-phase extraction (SPE) sorbent was demonstrated. The molecularly imprinted solid-phase extraction procedure followed by high performance liquid chromatography with ultraviolet detector (MISPE-HPLC) was developed for selective extraction and determination of tramadol in human plasma and urine. The optimal conditions for molecularly imprinted solid-phase extraction (MISPE) consisted of conditioning with 1 mL methanol and 1 mL of deionized water at neutral pH, loading of tramadol sample (50 µg L −1 ) at pH 7.5, washing using 1mL acetone and elution with 3×1 mL of 10% (v/v) acetic acid in methanol. The MIP selectivity was evaluated by checking several substances with similar molecular structures to that of tramadol. Results from the HPLC analyses showed that the calibration curve of tramadol (using MIP from human plasma and urine) is linear in the ranges of 6-100 and 3-120 µg L −1 with good precisions (1.9% and 2.9% for 5.0 µg L −1 ), respectively. The recoveries for plasma and urine samples were higher than 81%.
Introduction
Tramadol hydrochloride ( Fig. 1 ) (±) trans-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol is a synthetic, centrally acting, analgesic agent, used in the treatment of mild to moderate pain [1] . Its therapeutic concentration is within 100 to 300 µg L −1 [2] . After a single bolus infusion of 100 mg tramadol, concentrations in plasma can be detected instantaneously. Elimination is slow, being characterized by an elimination half-life of 6 h [2] . Tramadol is rapidly and almost completely absorbed after oral administration; but its absolute bioavailability is only 65-70% due to first-pass metabolism. Approximately 10-30% of the parent drug is excreted unmetabolised in the urine [2, 3] . Recent methods for its determination employed modified carbon paste electrode [4] , GC-MS [5] , GC with nitrogen-phosphate detection (NPD) [6] and LC-MS [7] . A number of high-performance liquid chromatographic (HPLC) methods with ultraviolet [8] [9] [10] , fluorescence [11] [12] [13] [14] [15] , electrochemical [16] and MS Figure 1 . Chemical structures of investigated drugs.
detection [17] HPLC-MS [18] have been described for the determination of tramadol, and its active metabolite (M1). Chiral HPLC methods [19] [20] [21] [22] [23] are very important for the determination of the enantiomeric ratios of tramadol and its metabolites. Most of them are, however, difficult and/or time-consuming, requiring a derivatisation step or a specific solvent extraction. Determination of tramadol in biological samples involves an initial sample pretreatment step for the isolation of target analytes, using liquid-liquid extraction (LLE) [24] [25] [26] [27] [28] [29] , prior to HPLC. However, this technique has many disadvantages as it is tedious, labor intensive, time consuming and very prone to loss of analyte. Nevertheless, an improved method for selective extraction and determination of tramadol is necessary.
LLE in particular requires the use of large amounts of high purity solvents, which are often hazardous, and result in the production of toxic laboratory waste. LLE also requires solvent evaporation in order to preconcentrate the analyte [30] . Analysis of pharmaceutical compounds in biological matrices such as serum requires sample pretreatment to clean-up the sample before the chromatographic separation, that can be commonly achieved by solid-phase extraction (SPE). SPE is the most popular of clean-up techniques because of factors such as convenience, cost, clean-up time, and simplicity.
Molecular imprinting is an attractive technique for the synthesis of highly selective polymeric receptors having artificial generated recognition sites which are able to rebind specifically a target molecule in preference to other closely related compounds [31] [32] [33] [34] [35] . The resulting molecularly imprinted polymers (MIPs) are stable, robust, and resistant to a wide range of pH, solvents, and temperature [36, 37] . The behavior of MIPs emulates the interactions established by natural receptors to retain selectively a target molecule (i.e., antibody-antigen) without the associated stability limitations. In addition, their preparation is relatively cheap and easy. In the last decade, one of the most promising technical applications, based on the use of MIPs, has been molecularly imprinted solid-phase extraction (MISPE). Most of the studies performed have focused on extracting compounds from biological samples [38] [39] [40] [41] [42] .
The use of MIPs for SPE can involve various modes, including conventional SPE where the MIP is packed into columns or cartridges [43, 44] and batch mode SPE where the MIP is incubated with the sample [45] . Another major advantage of MIP-based SPE, related to the high selectivity of the sorbent, is the achievement of an efficient sample clean-up. Compared to liquid-liquid extraction (LLE), SPE can reduce the time required, especially for automated methods, can handle small samples, and consumes small amount of solvent [46] . A study of tramadol imprinted polymers was reported by Boos et al. [47] . The study described how the imprinted polymers were prepared with EDMA as the cross-linker and MAA as functional monomer. The molar ratio of cross-linker, functional monomer and template was 20:4:1, that is different from this work. The study reveals, that a multidimensional Six-SPE sampleprocessing platform, which is based on the combination of two tailor-made packing materials (RAM-MIP), can provide useful information for us to understand the mechanism of molecular recognition and separation of a given sample (e.g. plasma, urine, etc).
The aim of the present work, is to demonstrate the feasibility of using MISPE by HPLC for the selective clean-up and quantification of trace amounts of tramadol from human plasma and urine.
Experimental Procedure

Chemicals and reagents
Methacrylic acid (MAA) from Merck (Germany) was distilled in vacuum prior to its usage in order to remove the stabilizers. Ethylene glycol dimethacrylate (EGDMA) and 2, 2-azobis isobutyronitrile (AIBN) from Sigma-Aldrich (Germany) were of reagent grade and were used without any further purification. All solvents used in chromatographic analyses were HPLC grade and supplied by Merck. Tramadol HCl, Dextromethorphan HBr, Pseudoephedrine HCl, diphenhydramine HCl, hydroxyzine HCl and cetirizine HCl were obtained from the ministry of health and medical education (Tehran, Iran), the degree of purity of all drugs were above 95%.
Apparatus
The HPLC system consisted of a Waters 515 pump, a 486Waters UV/vis detector, a model 7725i Rheodyne injector with a 25 µL sample loop and a micro-Bondapak C18 column of 4.6 mm × 150 mm HPLC column. HPLC data were acquired and processed using a PC and Millennium 2010 Chromatogram Manager software (Version 2.1 Waters). pH of solutions were adjusted using a model 630 digital Metrohm pH meter (Herisau, Switzerland) equipped with a combined glass-calomel electrode. FT-IR spectra of ground polymers were recorded on Bruker model EQUINOX 55. The thermal analysis of the polymer was carried out on a model PLSTA-1500 thermogravimetric analysis (TGA)-differential thermal analysis (DTA) instrument from Polymer Laboratories' Company (Shropshire, UK). 5.0 mg of the grounded polymer was heated at a heating rate of 5°C min −1 from ambient temperature up to 600°C under nitrogen atmosphere (flow rate = 20 mL min −1 ) and the corresponding TG curves were obtained.
Procedures
MIP and NMIP preparation with bulk polymerization
The schematic representation of the imprinting and the removal of tramadol from the imprinted polymer are shown in Fig. 2 . For the preparation of the tramadol imprinted polymer, the template (64 mg, 0.24 mmol) was dissolved in chloroform in a 25-mL thick walled glass tube. The functional monomer MAA (0.129 mL, 1.5 mmol), the cross-linker EGDMA (2.6 mL, 14 mmol), and the initiator AIBN (24 mg, 0.146 mmol) were then added to the above solution. The mixture was degassed under vacuum in a sonicating water bath while being purged with nitrogen for a period of 5 min. Maintaining a flow of nitrogen, the reaction flask was removed from the sonicating bath, sealed and placed inside a water bath at 60°C to begin the reaction. Under these conditions, the reaction was allowed to continue for 20 h. The product polymer, P (MAA-co-EGDMA), after drying in air overnight, was white and possessed a rigid structure. It was ground into fine particles using a mortar and pestle. Then, the polymer particles were washed with 10% (v/v) AcOH/MeOH for three times and with distillated water for two times. The complete removal of the template was followed by HPLC-UV, after three times washing the spectra of tramadol were not seen. In order to verify, that the retention of template was due to molecular recognition and not to non-specific binding, a control, non-imprinted polymer (NMIP) was prepared by the same procedure, including washing, but with the omission of the target molecule, tramadol. The size of the particles used after crushing and sieving was between 30 and 45 µm.
MISPE conditions
MIP and NMIP columns were prepared by packing 100 mg of the polymer into 2-mL empty cartridge. The cartridge was conditioned sequentially with 1 mL of methanol and 1 mL of deionized water. Extraction experiments involved loading the column with 5 mL, 50 µg L −1 tramadol (pH 7.5) at a flow rate of 1 mL min −1 . After loading, the column was washed with 1 mL of acetone, and a full vacuum was applied through the cartridge for 2min to remove residual solvent. Finally, the elution was performed by passing 3×1 mL of 10% (v/v) AcOH/MeOH, through the cartridge. All fractions were evaporated to dryness at 20°C under a stream of nitrogen and finally recovered in 1 mL of mobile phase. Then, 25 µL of each sample was injected onto the analytical column of HPLC.
Chromatographic conditions
The HPLC was carried out at room temperature. was selected as a mobile phase [48] . All of the analyses were carried out at an operation wavelength of 272 nm and the results were recorded by Millennium chromatography software.
Batch rebinding experiment
Batch adsorption experiments were used to evaluate the binding affinity of the imprinted polymer as previously reported [49, 50] . The general procedure for the extraction of tramadol by the MIP was as follows: tramadol standard solution prepared in water and the pH was adjusted at 7.5. Then, 50 mg of imprinted polymer were placed in 10-mL flask containing tramadol solutions of various concentrations (5-100 µg L -1 ). Each suspension was magnetically stirred for 1 h, and then passed through a paper filter (flow rate= 100 mL min -1 by applied vacuum). The free concentration of tramadol after the adsorption was recorded by HPLC-UV at 272 nm. Three replicate extractions and measurements were performed for each aqueous solution. The adsorbed tramadol was desorbed from the MIP by treatment with 5 mL of methanol and acetic acid (10:1, v/v, of 98% methanol and pure acetic acid). The extraction percentage of tramadol was calculated from Eq. 1.
where C i and C f are the concentrations of tramadol before and after extraction in the solution. The binding experiments were carried out in triplicate. In order to know that specific interactions and not the nonspecific ones which retain tramadol, the same procedure was followed for NMIP particles.
Standard solutions and calibration standards
Stock standard solutions of tramadol were prepared in water by adding appropriate volumes of tramadol solution to a 10-mL volumetric flask. The solution was then diluted to the mark with biological fluids and vortexed for 3 min. Each calibration curve consisted of 10 calibration points, covering 6-100 µg L −1 for plasma and 3-120 µg L −1 for urine. Calibration curves were determined by least square linear regression analysis. The peak area ratio of each analyte to tramadol versus the corresponding concentration was plotted.
Human plasma and urine samples preparation
Drug free human plasma was obtained from the Iranian blood transfusion service (Tehran, Iran) and stored at -20°C until use after gentle thawing. Urine was also collected from healthy volunteers (males, around 26-year old). 2 mL of the plasma and urine samples spiked by tramadol, were diluted with 2 mL buffer pH 7.5, and were centrifuged for 20 min at 8000 rpm, then filtered through a cellulose acetate filter (0.20 µm pore size, Advantec MFS Inc. CA, USA). The filtrate was collected in glass containers and stored at -20°C until analysis was performed. 2 mL of the filtered supernatant was collected to be directly percolated through the MIP or the NMIP.
Results and Discussion
Characterization
The IR spectra of NMIP 3 and the unleached and leached MIP 3 displayed similar characteristic peaks, indicating the similarity in the backbone structure of the different polymers. The IR spectra of the unleached and leached imprinted poly (MAA co-EGDMA) are shown in Fig. 3 . As a result of the hydrogen binding with the -COOH group of MAA, the C=O stretching, the OH stretching and the bending vibrations at 1710, 3457 and 1388 cm The FT-IR spectra of the imprinted and non-imprinted polymer after the extraction are similar indicating that the template was completely removed from the imprinted polymer. These data also suggested that the used drug did not interfere with the synthesis and recognition of the imprinted polymer, and was removed from the imprinted polymer after the extraction.
Thermo gravity analysis (TGA) plots of the unleached and leached MIP particles are plotted in Fig. 4 . Regarding the unleached MIP 3 particles, TGA revealed two decomposition states: one mass loss between 100 and 180°C (10% weight loss), assigned to the decomposition of the free monomer and the cross-linker, and one starting at 185°C, related to the tramadol hydrochloride decomposition as the melting point of tramadol hydrochloride is ~180-181°C [51] . All the materials were completely decomposed, prior to reaching the temperature of 460°C. These observations indicated, that the rigidity of the unleached and leached MIP 3 particles, is more than blank materials', as the former decomposes above ~300°C, while the latter starts to decompose at ~250°C onwards. Fig. 3 displays that the unleached and leached MIP particles have similar degradation patterns above 400ºC and after 450ºC, the complete decomposition of the polymeric matrix occurs.
Optimal MIP formulation and porogenic solvent
There are some variable parameters, influencing the final characteristics of the obtained materials, in terms of capacity affinity and selectivity for the target analyte, such as amount of monomer or nature of cross-linker and solvent. Solvent plays an important role in the formation of the porous structure of MIPs, which are a subset of a larger class known as macroporous polymers [52, 53] . The morphological properties of porosity and surface area are determined by the type of solvent, referred to as "porogen," used in the polymerization. Porosity arises from the phase separation from the porogen and the growing polymer during polymerization. Porogens with low solubility phase separate early and tend to form larger pores and materials with lower surface areas. Conversely, porogens with higher solubility phase separate later in the polymerization, providing materials with smaller pore size distributions and greater surface area. It does not appear, however, that binding and selectivity in MIPs are dependent on a particular porosity. In fact, optimal results are often obtained, when chloroform is used as porogen [54] .
The primary experiment revealed that the imprinted polymer prepared in chloroform shows a better molecular recognition ability than acetonitrile (ACN) and dimethylformamide (DMF) in aqueous environment. The specific adsorption recovery of tramadol in chloroform was 70%, while those prepared in DMF and ACN were 5 and 15%, respectively. DMF and ACN, (both strongly polar), easily disrupt binding between polymers and template. Therefore, chloroform was used to optimize the functional monomer to template ratio in order to improve molecular recognition capabilities. Generally, proper mole ratios of functional monomer to template are very important to enhance specific of polymers and number of MIPs recognition sites. A high ratio of functional monomers to template results in high non specific affinity, while low ratios produce fewer complication due to insufficient functional group [55] . Four molar ratios of the monomer MAA to the template (2:1, 4:1, 6:1 and 8:1) were used in the experiments. The optimum ratio of functional monomer to template, for the specific rebinding of bromhexine, was 6:1 (Table 1 ). This compound, had the best specific affinity and the highest recovery of 85%, while that of the corresponding NMIPs was low at 15%. The specific adsorption recovery of tramadol at 6:1 was 70%, while those at 2:1, 4:1 and 8:1 were 4%, 29% and 7%, respectively. Therefore, a typical 1:6:60 template:monomer:cross-linker molar ratio was used for further studies.
Effect of pH on drug loading
Different polymers with different template: monomer ratios were synthesized and pH effects were investigated on drug loading. The effect of pH on the sorption of tramadol was examined by varying the pH of solution from 2.0 to 10. Several batch experiments were performed by equilibrating 50 mg of the imprinted particles with 5 mL of solutions containing 50 µg L displayed that the pH has great effects on loading. The percentage of tramadol recovery increases with pH up to 7.5 and then decreases by further increase of pH.
A difference of about 70% between MIP 3 and NMIP 3 was seen at pH 7.5. while at pH 2, 4, 6, 9 and 10 were 42%, 52%, 64%, 65% and 50% respectively. The lower responses observed at lower and higher pHs might be attributed to the protonation of the functional group of tramadol and deporotonation of carboxyl groups of the polymer, respectively.
Choice of loading, washing, and eluent solution
Generally, the polymers have binding ability, with both specific and non-specific interactions. The specific interactions may originate mainly from the imprinting procedure, which creates selective recognition sites for the template. The non-specific interactions were assessed by measuring the binding of the non-imprinted polymer. In order to investigate the usefulness of washing step, various aqueous media including acetonitrile, acetone, tetrahydrofuran and dimethyl formamide were assessed for obtaining the maximum recovery of the analytes. A tramadol solution was employed for loading on MIP and NMIP cartridge, separately, followed by desorption with washing solvent. The results showed, that washing with tetrahydrofuran had no clear effect on the retention of tramadol on both MIP and NMIP cartridges. In contrast, polar organic solvents, such as acetonitrile, dimethyl formamide had evidently large effects on the retention of tramadol on both MIP and NMIP cartridges. It was seen that acetone can elute interferences and was chosen as the washing solution (Table 2 ). For the recovery of strongly bound tramadol, the polymers were eluted with 3×1 mL of 10% (v/v) AcOH/MeOH. With acetone, the recovery of tramadol in NMIP cartridge was decreased to 15%, while the recovery of tramadol by the MIP cartridges was not reduced (85%).
Capacity of polymers
The capacity of the sorbent is an important factor that determines how much sorbent is required to quantitatively remove a specific amount of drug from the solution [56, 57] . In the measurement of the adsorption capacity of MIP 3 and NMIP 3 absorbents, the absorbents (50 mg) were added to 10 mL tramadol solutions at concentrations of 1-500 µg L -1 . Then, the suspensions were mechanically shaken at room temperature, followed by centrifugally removing the absorbents. The remaining tramadol in the supernatant was measured by HPLC-UV. The adsorption isotherm (i.e., the number of milligram adsorbed per gram of adsorbent (Q) versus the equilibrium concentration) of tramadol is shown in Fig. 5 . According to these results, the maximum amount of tramadol that can be absorbed by MIP 3 , was found to be 81 mg g −1 (270 µmol g −1 ) at pH 7.5. As all the accessible specific cavities of the MIP 3 are saturated, the retention of the analyte is only due to non-specific interactions, which can be approximately identical for MIP and NMIP polymers.
Study of MIP Selectivity
Chromatographic evaluation and equilibrium batch rebinding experiments are the methods most commonly used to investigate the selectivity of the imprinted materials [58] . For equilibrium batch rebinding experiments, a known mass of template in solution is added to a vial containing a fixed mass of polymer. Once the system has reached the equilibrium, the concentration of free template in solution is measured and the mass of template absorbed to the MIP is calculated [59, 60] . Dextromethorphan, pseudoephedrine and diphenhydramine as antitussive (cough suppressant) drugs, hydroxyzine as antihistamines and cetrizine as an active metabolite of hydroxyzine were selected to investigate the selectivity of the MIP. Their molecular structures are shown in Fig. 1 . Solutions of all compounds were prepared individually at a concentration of 50 µg L −1 . The extraction solvent was 10% (v/v) AcOH/MeOH. The extraction yields of the selected compounds with the MIP and NMIP are shown in Fig. 6 . Noticeably, the extraction yields of analogues with the MIP were much higher than that of the NMIP. It was revealed that the tramadol based-MIP possess better affinity to the template molecule. This affinity is mainly caused by the hydrogen bonding interaction between functional groups possessed by all drugs and carboxylic groups in the MIP. This could be simply explained by their close similarity to tramadol in the arrangement of the functional groups, and in the size of the three-dimensional structure.
Tramadol assay in human plasma and urine samples
To demonstrate the potential of MIP for the sample clean-up, the MIP was applied to the purification of spiked tramadol (TRM) at the three levels in human plasma and urine. Aqueous media was employed for the loading solution, and the wash procedure was assessed for obtaining maximum recovery of the analytes using acetone. The chromatograms obtained for plasma and urine samples are shown in Figs. 7 and 8. As shown in these figures, this efficient method allowed cleaner extracts to be obtained and interfering peaks arising from the complex biological matrices to be suppressed. with good precision (1.9% for and 2.9% for 50 µg L −1 ), respectively. The repeatability for 5 mL of spiked plasma and urine (50 µg L −1 of TRM), expressed as RSD (n = 6), was lower than 4%. The recoveries for both plasma and urine were more than 81% (Table 3) . Typical chromatograms (presented in Figs. 7 and 8 ) reveal that the MIP can be used for the sample clean up. The limit of detection (LOD) and limit of quantification (LOQ) for TRM in plasma samples were 3 and 12 µg L −1 , respectively. These limits for TRM in urine samples were 1.2 and 5 µg L −1 , respectively.
Conclusion
This study shows, for the first time, the synthesis and the application in SPE of a polymer imprinted following a conventional non-covalent molecular imprinting protocol using tramadol as a template. In this work, data and results show that MIPs as sorbents for SPE are better at selectivity and adsorptive capacity than NMIPs which are prepared without tramadol as template by bulk polymerization. It shows that MIPs possess larger pore volume and more recognition sites than NMIPs.
The method was applied to the trace tramadol determination; the recoveries for the spiked human plasma and urine samples were higher than 81% in the 25-75 µg L −1 . It could be concluded that the technique has great potential in developing selective extraction method for other compounds.
a Average of three determinations. Table 3 . Assay of tramadol in human plasma and urine by means of the described MISPE procedure.
